BHV Partners

bhvpartners.com ↗ ·Barcelona ·Seed

BHV Partners is a Barcelona-based venture builder specialising in healthcare. It creates start-ups that turn research from universities, hospitals and research centres into products across therapeutics, medical devices, digital health, in-vitro diagnostics and nutrition, and it also advises technology-transfer offices, start-ups and the biomedical industry. It was founded in 2019 by Marta Príncep, Albert G. Zamora, Joan Bigorra and Joaquim Trias, and has built companies including Adan Medical, Aimentia, Biel Glasses, MATCH Biosystems and Conus Airway, with teams in Barcelona, San Sebastián and San Francisco. It is backed by a base of private investors and an ENISA participation loan, has raised about €1.2 million, and later opened a €2.5 million seed round aimed at family offices and corporate venture funds.

Founded
2019
Founders
4
Total funds raised
€500K
Rounds
1
Investors
1
Last round
Oct 2020
SectorsHealthtech, Biotech, Medtech, Digital Health, Diagnostics, Venture Building Start-up MapHealthtech & Bio › Drug discovery & therapeutics developers

Suggest a correction

Founders

Albert G. Zamora
Co-Founder & Chairman
Joan Bigorra
Co-Founder & Advisor to the Board
Joaquim Trias
Co-Founder & Board Member
Marta Príncep
Co-Founder & CEO

Global models 5

Roivant Sciences
United States · roivant.com ↗
Creates and runs a portfolio of subsidiary biotech companies ('Vants') built around licensed drug assets, the same company-building model BHV uses.
$2.0BComparable
ElevateBio
United States · elevate.bio ↗
Starts and operates new cell and gene therapy companies from academic and partner science, a healthcare company-creation model like BHV's.
$1.2BComparable
BridgeBio Pharma
United States · bridgebio.com ↗
Licenses research from universities and research centres and spins each program into its own subsidiary company, a hub-and-spoke version of BHV's model.
$800MComparable
Apollo Therapeutics
United Kingdom · apollotx.com ↗
Turns research from partner universities (Cambridge, Imperial, UCL) into therapeutics programs and companies, closely matching BHV's tech-transfer company creation.
$450MComparable
Redesign Health
Healthcare venture builder that designs, launches and staffs new health start-ups, the same studio model as BHV.
$365MComparable

In the same niche 67 others

See all in the Start-ups Map →

Notes: Most funded first

Investors 1

Open as list →

Funding rounds 1

·1 not counted
DateRoundAmountLead
Not counted (1)

Not counted in totals

PublishedArticle
2024-01-02 BHV Partners appoints Albert Mascarell as new CEO ↗
BioSpace
2024-01-02
Start typing to search across everything.
↑↓ navigate↵ openesc close? shortcuts
Keyboard shortcuts
/ Ctrl K
Search
j k
Next or previous row
↵
Open the row
Ctrl ↵
Open it in a new tab
[ ]
Previous or next page
?
This list